Xvivo Perfusion AB (LTS:0RKL)
kr 235.11 -23.5 (-9.09%) Market Cap: 7.34 Bil Enterprise Value: 7.16 Bil PE Ratio: 82.62 PB Ratio: 3.34 GF Score: 84/100

Xvivo Perfusion AB at JPMorgan Healthcare Conference Transcript

Jan 14, 2026 / 12:30 AM GMT
Release Date Price: kr215.02 (+7.16%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

XVIVO.ST - Xvivo Perfusion AB
Xvivo Perfusion AB at JPMorgan Healthcare Conference
Jan 15, 2026 / 12:30AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Okay, our next presentation is about to start. You take your conversation out, thank you.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Hi everyone, I hope you've enjoyed day 3 of the JPMorgan Healthcare Conference. My name is Vidushi Tauri, and I'm an associate in the healthcare team here at JPM. It's my pleasure to introduce X Vivo CEO Christopher Rosenblatt, who will be presenting to you today. Over.

--------------------------------------------------------------------------------
Unidentified_3 [3]
---------------------------------------------------
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot